CD34 Evaluation of Microvasculature in Lung Adenocarcinoma and Its Microvascular Density Predicts Postoperative Tumor Recurrence

Overview

Journal Pathol Oncol Res

Date 2025 Feb 5

PMID 39906069

Authors

Zijian Qiu

Jiaji Wu

Guanchao Pang

Xia Xu

Jun Lin

Pingli Wang

Affiliations

Soon will be listed here.

Abstract

Background: Angiogenesis is closely associated with tumor growth and metastasis, and microvascular density (MVD) is currently the clinical standard for evaluating tumor angiogenesis. Thus, the detection of intratumoral MVD is of great significance for understanding disease progression and predicting patient prognosis.

Methods: Tumor tissue sections of 238 patients with lung adenocarcinoma (LUAD) who underwent radical surgery were retrospectively analyzed. Immunohistochemical (IHC) staining was carried out using a CD34 polyclonal antibody to determine intratumoral MVD, and the relationship of CD34-MVD with the clinicopathological characteristics and survival time of LUAD patients was analyzed.

Results: CD34-MVD was associated with tumor size, lymph node metastasis, tumor recurrence, and patient survival status; patients with tumor size ≤3 cm ( = 0.015), negative for lymph node metastasis ( = 0.049), no tumor recurrence ( = 0.021), and survival ( = 0.042) had higher MVD. Survival analysis suggested that patients with high MVD had higher disease-free survival (log-rank = 0.005) and overall survival (log-rank = 0.004) compared to patients with low MVD. The Cox proportional hazards model showed that a high MVD ( = 0.022) reduced the risk of postoperative tumor recurrence in patients with LUAD.

Conclusion: Decreased intratumoral CD34 positive microvessels were associated with tumor development in patients with LUAD. CD34-MVD is an independent risk factor affecting postoperative tumor recurrence in patients with LUAD and can be used as a prognostic indicator for this group of patients.

References

Qi J, Li M, Wang L, Hu Y, Liu W, Long Z . National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health. 2023; 8(12):e943-e955. DOI: 10.1016/S2468-2667(23)00211-6. View

Yao X, Qian C, Zhang Z, Tan M, Kort E, Yang X . Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res. 2007; 13(1):161-9. DOI: 10.1158/1078-0432.CCR-06-0774. View

Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M . Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res. 2001; 7(11):3410-5. View

Muraoka Y, Yotsukura M, Yoshida Y, Nakagawa K, Shiraishi K, Kohno T . Dynamics of recurrence after curative resection of nonsmall cell lung cancer. J Surg Oncol. 2023; 128(7):1205-1212. DOI: 10.1002/jso.27395. View

Zhang Y, Vaccarella S, Morgan E, Li M, Etxeberria J, Chokunonga E . Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol. 2023; 24(11):1206-1218. DOI: 10.1016/S1470-2045(23)00444-8. View

Liu D, Ding G . Predictive value of microvascular density for response to anlotinib in advanced NSCLC. Medicine (Baltimore). 2022; 101(3):e28647. PMC: 8772671. DOI: 10.1097/MD.0000000000028647. View

Meira D, de Castro E Caetano M, Casotti M, Zetum A, Goncalves A, Moreira A . Prognostic Factors and Markers in Non-Small Cell Lung Cancer: Recent Progress and Future Challenges. Genes (Basel). 2023; 14(10). PMC: 10606762. DOI: 10.3390/genes14101906. View

Pomme G, Augustin F, Fiegl M, Droeser R, Sterlacci W, Tzankov A . Detailed assessment of microvasculature markers in non-small cell lung cancer reveals potentially clinically relevant characteristics. Virchows Arch. 2015; 467(1):55-66. DOI: 10.1007/s00428-015-1767-y. View

Yugawa K, Itoh S, Yoshizumi T, Iseda N, Tomiyama T, Toshima T . Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes. Mod Pathol. 2020; 34(4):798-807. DOI: 10.1038/s41379-020-00702-9. View

10.

Yildiz E, Ayan S, Goze F, Gokce G, Gultekin E . Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. BJU Int. 2007; 101(6):758-64. DOI: 10.1111/j.1464-410X.2007.07318.x. View

11.

Sopo M, Anttila M, Muukkonen O, Yla-Herttuala S, Kosma V, Keski-Nisula L . Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors. Anticancer Res. 2020; 40(12):6923-6931. DOI: 10.21873/anticanres.14716. View

12.

Zhao Y, Xue C, Jiang W, Zhao H, Huang Y, Feenstra K . Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab. J Thorac Oncol. 2011; 7(1):71-5. DOI: 10.1097/JTO.0b013e31823085f4. View

13.

Schegoleva A, Khozyainova A, Fedorov A, Gerashchenko T, Rodionov E, Topolnitsky E . Prognosis of Different Types of Non-Small Cell Lung Cancer Progression: Current State and Perspectives. Cell Physiol Biochem. 2021; 55(S2):29-48. DOI: 10.33594/000000340. View

14.

Bing Z, Jian-ru Y, Yao-quan J, Shi-feng C . Evaluation of angiogenesis in non-small cell lung carcinoma by CD34 immunohistochemistry. Cell Biochem Biophys. 2014; 70(1):327-31. DOI: 10.1007/s12013-014-9916-5. View

15.

Adamo A, Bruno A, Menallo G, Francipane M, Fazzari M, Pirrone R . Blood Vessel Detection Algorithm for Tissue Engineering and Quantitative Histology. Ann Biomed Eng. 2022; 50(4):387-400. PMC: 8917109. DOI: 10.1007/s10439-022-02923-2. View

16.

Weis S, Cheresh D . Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011; 17(11):1359-70. DOI: 10.1038/nm.2537. View

17.

Donnem T, Al-Saad S, Al-Shibli K, Delghandi M, Persson M, Nilsen M . Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer. Clin Cancer Res. 2007; 13(22 Pt 1):6649-57. DOI: 10.1158/1078-0432.CCR-07-0414. View

18.

Zhang Q, Wu J, Bai X, Liang T . Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas. Front Med (Lausanne). 2020; 7:584250. PMC: 7652932. DOI: 10.3389/fmed.2020.584250. View

19.

Nico B, Benagiano V, Mangieri D, Maruotti N, Vacca A, Ribatti D . Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol. 2008; 23(5):601-7. DOI: 10.14670/HH-23.601. View

20.

Carlini M, Dalurzo M, Lastiri J, Smith D, Vasallo B, Puricelli L . Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance. Hum Pathol. 2009; 41(5):697-705. DOI: 10.1016/j.humpath.2009.04.029. View